首页 | 本学科首页   官方微博 | 高级检索  
     

喉咽反流性疾病的临床治疗研究
引用本文:陈寻,杨云,陈智斌. 喉咽反流性疾病的临床治疗研究[J]. 山东大学耳鼻喉眼学报, 2016, 30(1): 67-69. DOI: 10.6040/j.issn.1673-3770.0.2015.433
作者姓名:陈寻  杨云  陈智斌
作者单位:1. 南京医科大学, 江苏 南京 210029;2. 江苏盛泽医院耳鼻咽喉头颈外科, 江苏 苏州 215228
摘    要:
目的 探讨喉咽反流性疾病(LPRD)的诊疗方法,同时观察LPRD患者幽门螺杆菌检出率。 方法 156例反流症状指数(RSI)>13分和/或反流体征指数(RFS)>7分临床确诊为LPRD的患者,进行13C-尿素呼气试验(13C-UBT)[4]检测,检出Hp阳性患者(I组)进行2周的幽门螺杆菌四联疗法[5](奥美拉唑+枸橼酸铋钾+阿莫西林+克林霉素)+甘桔冰梅片治疗后停药4周,观察Hp转阴率及LPRD转阴率;将Hp阴性患者随机分为2组,II组30例单纯给予甘桔冰梅片治疗4周后观察LPRD转阴率,III组30例给予奥美拉唑+莫沙必利+甘桔冰梅片治疗4周后观察LPRD转阴率。 结果 Hp阳性检出率为61.54%(96/156),经治疗2周后停药,4周复查Hp转阴率为78.12%(75/96),I组治疗后LPRD转阴率为67.71%(65/96),II组转阴率为53.33%(16/30),III组转阴率为96.67%(29/30)。经治疗后,三组RSI和RFS评分均较治疗前降低,差异有统计学意义(t=6.73,P<0.001)。治疗后III组与II组比较,III组的RSI和RFS评分更低。 结论 喉咽反流是导致咽喉炎的重要病因,使用抑酸剂及消化道促动力剂可明显改善喉咽反流的症状及体征。

关 键 词:幽门螺杆菌  喉咽反流性疾病  13碳尿素呼气试验  幽门螺杆菌四联疗法  
收稿时间:2015-10-19

Research on diagnosis and treatment of laryngopharyngeal reflux disease
CHEN Xun,YANG Yun,CHEN Zhibin. Research on diagnosis and treatment of laryngopharyngeal reflux disease[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2016, 30(1): 67-69. DOI: 10.6040/j.issn.1673-3770.0.2015.433
Authors:CHEN Xun  YANG Yun  CHEN Zhibin
Affiliation:1. Nanjing Medical University, Nanjing 210029, Jiangsu, China;2. Department of Otolaryngology &Head Neck Surgery, Jiangsu Shengze Hospital, Suzhou 215228, Jiangsu, China
Abstract:
Objective To discuss the diagnosis and treatment method of laryngopharyngeal reflux disease (LPR D), and to observe the detection rate of helicobacter pylori from the patients with LPR D.Methods A Total of 156 LPR D patients with reflux symptom index (RSI)over 13 and/or reflux symptom index (RFS)>7 were supplied with 13 C-U-rea Breath Test (13 C-UBT).The Hp positive patients (n =96,group I)were administrated with quadruple therapy (Omeprazole +Bismuth Potassium Citrate +Amoxicillin +Clindamycin)and Ganju Bingmei tablets for 2 weeks,fol-lowed up with a 4 weeks of withdrawal period.The primary ourcome observed was of Hp negative transformation rate and curative effect evaluation before and after the treatment; Hp negative patients were divided into group II and group III,with 30 cases in each group.The group II was given Ganju Bingmei tablets for 4 weeks and the group III was ad-ministrated with Omeprazole +Bismuth Potassium Citrate and Ganju Bingmei Tablets for 4 weeks.The main outcome was LPR Dand HP negative-converting rate.Results The Hp negative-converting rate was 78.12% (75 /96)in group I.The LPR Dnegative-converting rate in group I,group II and group III was 67.71%(65 /96),53.33%(16 /30)and 96.67%(29 /30),respectively.The score of RSI and RFS were decreased in all three groups after treatment,and dropped more significantly in group III (Statistic:6.73,P <0.001).Conclusion Laryngopharyngeal reflux,as an im-portant cause of sphagitis,can be improved by using antiacid and gastrointestinal prokinetic agents.
Keywords:Laryngopharyngeal reflux disease  Helicobacter pylori  13 C-Urea Breath Test  Helicobacter pylori quadrup-le therapy
本文献已被 万方数据 等数据库收录!
点击此处可从《山东大学耳鼻喉眼学报》浏览原始摘要信息
点击此处可从《山东大学耳鼻喉眼学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号